Skip navigation


Community and Patient Preference Research (CaPPRe) - Research Study - Understanding treatment preferences of people living with migraine

Understanding treatment preferences of people living with migraine

You are invited to take part in a research study that is being conducted by an independent research
company, Community and Patient Preference Research (CaPPRe).

CaPPRe are experts in treatment preference research. They work closely with industry, academia, and government to encourage patient involvement and choice in healthcare decision-making. CaPPRe has been sponsored by a pharmaceutical company to investigate treatment preferences in the area of migraine.

Purpose of the Study
The purpose of this study is to explore the experience of living with migraine, with a focus on what is important to people when it comes to treatment. That is, what are the key treatment attributes that people living with migraine value?

Your participation is valuable in exploring the issues people living with migraine encounter during treatment. This information helps improve the understanding of what is important to people living with migraine in the care and treatment of this condition. The research is sponsored by a pharmaceutical company.

What’s Involved?
A 20-25 -minute online survey where you will be asked some questions about the impact of migraine on your life. You will also be asked about the diagnostic and treatment pathway and discuss different treatment options and your preferences.

To compensate your time and contribution to the research, you will receive $ 45 as an honorarium, via e-gift card (we would collect your details for this - please note that your contact details would only be used for the purpose of sending the honorarium to you and will be deleted after this has been sent).

How to register your interest in this study?
To see if you are eligible and would like to register your interest and start the survey, please click on the following link: https://survey.confirmit.com.au/wix/p461059782600.aspx?source=MA


Should you require more information or would like to participate please contact Samson Kong at [email protected]

Continue Reading

Read more